Drug Shortage Report for DILANTIN-30 SUSPENSION
Report ID | 76444 |
Drug Identification Number | 00023442 |
Brand name | DILANTIN-30 SUSPENSION |
Common or Proper name | DILANTIN-30 SUSPENSION |
Company Name | UPJOHN CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | PHENYTOIN |
Strength(s) | 30MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL |
Packaging size | 250ML |
ATC code | N03AB |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-05-23 |
Actual start date | |
Estimated end date | |
Actual end date | 2019-05-06 |
Shortage status | Avoided shortage |
Updated date | 2019-05-07 |
Company comments | |
Health Canada comments | |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-833-287-5646 Email / courriel: UpjohnCanadaCustomerService@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.